How Public Funding Prepares Deep Tech Startups for VCs and Builds Company Value

Used well, public deep tech funding is not an alternative to VC, but a part of the financing sequence that can take a startup to its first institutional round with less risk, less dilution, and a stronger negotiating position.

Deep tech needs years of capital-intensive development before generating revenue, while most VC funds want proof of market pull within one fund cycle. Between the two lies the valley of death, precisely the zone public deep tech funding is designed to cover.

Across those markets and instruments, the companies that gain the most treat public funding as the first chapter of their financing strategy, not as a side project run by a grants team.

The objective is not simply to win a grant. It is to use the right source of capital at the right stage to finance the proof points that make the company more investable. 

Below are the four mechanisms behind that effect, what the evidence shows, and where founders get it wrong.

The funding ladder, and the routes around it  

The EIC now offers an instrument for every stage between a research result and a Series B, and the 2026 work program puts €1.4 billion behind it.

The EIC Accelerator is the rung where public money and VC meet: its grant de-risks the technology, and its equity anchors the first institutional round. Above it, public capital moves to equity only, invested alongside private funds on market terms. National schemes, Eurostars and regional deep tech funds feed the lower rungs.

That ladder is useful, but it is not the only route. In practice, companies often combine collaborative Horizon Europe or Digital Europe projects, Eurostars and national schemes before they are ready for an EIC-style individual instrument or a VC round. The strategic question is therefore not “Which grant can I win?” but “Which financing instrument funds the next proof point without distorting the company’s commercial path?”

Mechanism 1: Non-dilutive capital buys de-risking at zero equity cost

A grant funds the riskiest milestones without selling shares at the company’s lowest-ever valuation. That is the core of the value effect.

Consider an illustrative case. A startup needs €2.5 million to advance a prototype from TRL 6 to a validated pilot. If it raises that money as equity at a €10 million pre-money valuation, it costs 20% of the company. Funded through an EIC Accelerator grant, it costs no equity; the company raises its next round after the pilot works, at a valuation that reflects reduced technical risk.

The founders end up owning more of a more valuable company. Later investors also benefit: a cleaner cap table with motivated founders is easier to build a syndicate around.

Two caveats apply. The EIC grant covers 70% of eligible costs, so the company must fund the remaining 30% itself. The extra runway only creates value if it is spent on the milestones that investors are pricing, not on side projects.

Mechanism 2: The evaluation works as free, front-loaded due diligence

In our experience, strong technology is rarely enough to carry a deep tech proposal. Evaluators also test whether the company can turn that technology into a credible investment case: the right maturity for the instrument, a defined market, defensible differentiation, a realistic route to customers, and a coherent use of funds. These are many of the same questions a VC partner will ask a few months later.

Three gaps recur:

• The first is a mismatch between actual maturity and the instrument: a TRL 4 lab prototype pitched to the Accelerator, or a near-market product pitched to Pathfinder. 
• The second is a commercial section that fails to specify who buys, at what price, against whom, and through which channel; technology readiness and business readiness are different scales, and juries score both. 
• The third, more recent, is proposals drafted largely with AI tools: fluent on the surface, internally inconsistent underneath, and quickly spotted by seasoned evaluators. The 2026 work program cut the full proposal from 50 to 20 pages, which makes these gaps more visible, not less.

The EIC label carries weight, though less than founders often assume. In the most rigorous US study, Howell found that the grant's effect on venture funding was not primarily a quality signal; the money helped by funding prototyping that reduced investor uncertainty. The badge gets you the meeting; the de-risked technology closes the round. And with only 3 to 5% of applicants progressing from first submission to a funded project, the discipline of preparing is part of the value, whether you win.

Mechanism 3: Public equity crowds private VC in

The EIC Fund is built to co-invest, not to go it alone, and the leverage it reports has risen every year. Each euro it invests has been matched by €3.5 from other investors, with more than 1,000 investors co-investing alongside the EIC (EIC Impact Report 2026). That ratio was €2.6 in the 2022 report and over €3 in the 2025 report (EIC, 2022; EIC, 2025).

The structure explains why. The EIC Fund takes minority stakes of up to 25% and invests up to €10 million per company. Its investment guidelines direct it to seek co-investors who at least match its ticket size.

For a VC, a patient public co-investor reduces the capital it must commit to a technically risky round. For the startup, an EIC equity commitment can anchor a round that would otherwise not close, and the round size itself supports the valuation. Above that stage, STEP Scale Up offers €10 to 30 million in equity-only tickets, and the new €5 billion Scaleup Europe Fund targets Series B and beyond with tickets of around €100 million.

Mechanism 4: Grant discipline builds the operating habits VCs buy into

Running a funded deep-tech project establishes the governance institutional investors expect. Milestones are contractual, budgets are tracked against deliverables, and progress is reported to an external party on a fixed schedule.

That discipline shows up in the data room. A company that has delivered on a grant agreement can show a track record of hitting technical milestones on budget, which is exactly what a Series A investor is trying to judge.

The EIC adds a layer on top. Its Business Acceleration Services connect beneficiaries with corporates, investors and coaches, and its co-investment support program prepares companies to pitch to investors. When the EIC Fund invests, it also actively follows its companies, bringing board-level discipline earlier than most seed-stage firms adopt on their own.

Early grants might double the odds of raising private equity

Two quasi-experimental studies, one American and one European, compare firms just above and just below the funding cut-off. Both find that a grant roughly doubles the likelihood of later private equity. Program data from the EIC points the same way, though it is self-reported and not causal.

Where it goes wrong

Public funding adds value only when it fits the company's financing plan. Six mistakes recur.

• Applying before you are ready. If maturity, the commercial case or the IP position is not in place, my advice to clients is not to apply this round. A rejected proposal costs 9 to 12 months; one not yet submitted still leaves time to build it properly.
• Treating blended finance as free money. The EIC equity component is real equity on market terms, with the EIC Fund as a minority shareholder. Model its dilution and governance rights like any other term sheet.
• Mistiming the application. Evaluation and contracting take months. A company with six months of cash cannot wait for a grant decision; one that applies 12 to 18 months ahead can use it to shape the round.
• Deferring IP until after the seed round. Evaluators will ask about freedom to operate, and an exploitation plan without filed IP reads as aspirational. A defensible patent position on the core differentiator is also leverage in the later VC negotiation.
• Grant dependency. A company that chains grants without testing market signals tells VCs it is optimising for evaluators, not customers; again, non-dilutive funding should not be the goal, but only one tool to help the team focus on getting their solutions to market and, consequently, scaling up.
• Thresholds that move. The 2026 programme raised the minimum equity component from €0.5 million to €1 million. Rules change yearly, so a strategy built on last year's call document can fail on eligibility alone.

A founder's playbook

This is how we sequence it with clients, before, during and after a grant award. In practice, the financing path is rarely one instrument: collaborative R&D, Eurostars-type projects, national schemes, demonstration funding and equity can each have a role at different stages. The aim is for each source of capital to pay for proof points that increase readiness for the next one, rather than becoming an end in itself.

1. Check readiness honestly. Score the company on technology and business readiness separately. If either is weak, fix it before applying, not inside the proposal.
2. Map the round you want to raise in 18 to 24 months. Name the technical and commercial proof points that round will be priced on.
3. Match each proof point to an instrument. Pathfinder and Transition for early validation, the Accelerator grant for TRL 6 to 8 demonstration, Accelerator equity or STEP Scale Up when the market case is ready.
4. Write the application as an investment memo. Use the same use-of-funds, milestones and market logic as the pitch deck, so the work does double duty.
5. Bring VCs in early. Tell target investors you are applying; an award then lands as confirmation of a story they already know, and their interest strengthens the equity case.
6. Plan the co-investment before the grant award. If you request blended finance, line up who will join the round so the EIC Fund's ticket is matched quickly.
7. Report as if to a board. Treat grant milestones as investor updates. The reporting archive becomes your best due diligence evidence.

Build the grant into the financing plan

Deep tech funding can increase company value by changing what a startup looks like when it meets venture capital: lower technical risk, less early dilution, stronger governance, and, in some cases, a public co-investor already at the table. Evidence from both sides of the Atlantic suggests the effect is strongest when public money arrives early enough to resolve uncertainties private investors are not yet willing to finance.

European deep tech rarely struggles for lack of technological ambition. More often, the weakness lies in what surrounds the technology: commercial readiness, IP strategy, financing sequence and the ability to translate technical progress into an investable business case. Public funding works best when it is built into that journey from the beginning: financing milestones that reduce risk, strengthen the company and make the next source of capital easier to access.